← Leaderboards
Chester B Whitley
University Of Minnesota Twin Cities
$15,153,874
Attributed
$15,153,874
Total exposure
42
Grants
39
Lead (contact PI)
Attributed= this PI's even-split share of every grant they're on (the fair, additive number). Exposure = full size of all those grants. They are the sole PI on all grants (the two match).
Funding over time
peak $4.3M · FY2005–24$5M$3.8M$2.5M$1.3M$0
'05
'06
'07
'08
'09
'10
'11
'12
'13
'14
'15
'16
'17
'18
'19
'20
'21
'22
'23
'24
Funding mix
By agency
NIH$47,381,977 · 44
By mechanism
U54$25,462,989 · 15
P01$21,540,205 · 8
R13$233,901 · 8
M01$124,882 · 12
U13$20,000 · 1
Top collaborators
No co-investigators on record.
Most similar at University Of Minnesota Twin Cities
Same institution · by research overlap
- Carston R. Wagner$9,182,483
- Elsa G Shapiro$765,873
- Darrin M. York$15,166,157
- Margot P Cleary$2,810,750
- R Scott McIvor$12,592,678
Others in their field
Top investigators on “Research Personnel”
- David Heimbrook · Leidos Biomedical Research, Inc.$701,463,488
- Sonia M Thomas · Research Triangle Institute$700,865,642
- Leonard Freedman · Leidos Biomedical Research, Inc.$557,978,666
- Tracy L Nolen · Research Triangle Institute$474,487,152
- David R. Weir · University Of Michigan At Ann Arbor$364,053,504
- Judith S. Currier · University Of California Los Angeles$284,675,012
Research focus
Research PersonnelGene TherapyAffectMucopolysaccharidosis IMedicalProgramsResearch Project GrantsFundingPhenotypeEnzymesMeetingsLifeLysosomesInnovationNeonatal ScreeningInterestGenotypeInstructionNatural HistoryRare DiseasesBrainMucopolysaccharidosesSymposiumStructure
Grant awards (139)
Lysosomal Disease Network$688,209
U54 · FY2024 · NS · contact PI
MPS Disease Longitudinal Study of Treatment and Outcomes Across the Lifespan$265,810
U54 · FY2024 · NS · contact PI
Lysosomal Disease Network Administrative Core$159,695
U54 · FY2024 · NS · contact PI
Career Enhancement Core$43,938
U54 · FY2024 · NS · contact PI
Lysosomal Disease Network Pilot Core$43,938
U54 · FY2024 · NS · contact PI
Lysosomal Disease Network$1,125,055
U54 · FY2023 · NS · contact PI
MPS Disease Longitudinal Study of Treatment and Outcomes Across the Lifespan$433,131
U54 · FY2023 · NS · contact PI
Lysosomal Disease Network Administrative Core$264,122
U54 · FY2023 · NS · contact PI
Career Enhancement Core$72,671
U54 · FY2023 · NS · contact PI
Lysosomal Disease Network Pilot Core$72,671
U54 · FY2023 · NS · contact PI
Lysosomal Disease Network$1,127,583
U54 · FY2022 · NS · contact PI
MPS Disease Longitudinal Study of Treatment and Outcomes Across the Lifespan$433,685
U54 · FY2022 · NS · contact PI
Lysosomal Disease Network Administrative Core$264,092
U54 · FY2022 · NS · contact PI
Career Enhancement Core$72,663
U54 · FY2022 · NS · contact PI
Lysosomal Disease Network Pilot Core$72,663
U54 · FY2022 · NS · contact PI
Lysosomal Disease Network$1,130,163
U54 · FY2020 · NS · contact PI
MPS Disease Longitudinal Study of Treatment and Outcomes Across the Lifespan$434,230
U54 · FY2020 · NS · contact PI
Lysosomal Disease Network Administrative Core$264,061
U54 · FY2020 · NS · contact PI
Career Enhancement Core$72,654
U54 · FY2020 · NS · contact PI
Lysosomal Disease Network Pilot Core$72,654
U54 · FY2020 · NS · contact PI
Lysosomal Disease Network$1,239,211
U54 · FY2019 · NS · contact PI
MPS Disease Longitudinal Study of Treatment and Outcomes Across the Lifespan$449,649
U54 · FY2019 · NS · contact PI
Lysosomal Disease Network Administrative Core$273,398
U54 · FY2019 · NS · contact PI
Career Enhancement Core$73,404
U54 · FY2019 · NS · contact PI
Lysosomal Disease Network Pilot Core$73,404
U54 · FY2019 · NS · contact PI
Lysosomal Disease Network$1,113,003
U54 · FY2018 · NS · contact PI
RDCRC Administrative Unit$340,658
U54 · FY2018 · NS · contact PI
Longitudinal Studies of Brain Structure and Function in MPS Disorders$167,960
U54 · FY2018 · NS · contact PI
Training (Career Development) and Education Component$83,600
U54 · FY2018 · NS · contact PI
Natural History of Hexosaminidase Deficiency and Other Gangliosidoses and Synger-G$52,417
U54 · FY2018 · NS · contact PI
Lysosomal Disease Network$1,119,821
U54 · FY2017 · NS · contact PI
RDCRC Administrative Unit$344,944
U54 · FY2017 · NS · contact PI
Longitudinal Studies of Brain Structure and Function in MPS Disorders$167,960
U54 · FY2017 · NS · contact PI
Training (Career Development) and Education Component$83,600
U54 · FY2017 · NS · contact PI
Natural History of Hexosaminidase Deficiency and Other Gangliosidoses and Synger-G$52,417
U54 · FY2017 · NS · contact PI
Gene Therapy for Metabolic Disorders$1,198,672
P01 · FY2016 · HD · contact PI
Lysosomal Disease Network$1,117,216
U54 · FY2016 · NS · contact PI
RDCRC Administrative Unit$343,259
U54 · FY2016 · NS · contact PI
SB Transposons for Gene Therapy$278,730
P01 · FY2016 · HD · contact PI
AAV Mediated Gene Therapy to the CNS for MPS I$250,166
P01 · FY2016 · HD · contact PI
In Vivo Lentiviral Gene Therapy for Hurler Syndrome$240,173
P01 · FY2016 · HD · contact PI
Neuro-Histology & Behavior$183,539
P01 · FY2016 · HD · contact PI
Longitudinal Studies of Brain Structure and Function in MPS Disorders$167,960
U54 · FY2016 · NS · contact PI
Research Animal Care and Medicine$132,868
P01 · FY2016 · HD · contact PI
Administration$113,196
P01 · FY2016 · HD · contact PI
Training (Career Development) and Education Component$83,600
U54 · FY2016 · NS · contact PI
Natural History of Hexosaminidase Deficiency and Other Gangliosidoses and Synger-G$52,417
U54 · FY2016 · NS · contact PI
Lysosomal Disease Network$1,232,324
U54 · FY2015 · NS · contact PI
RDCRC Administrative Unit$341,290
U54 · FY2015 · NS · contact PI
Longitudinal Studies of Brain Structure and Function in MPS Disorders$167,960
U54 · FY2015 · NS · contact PI
Training (Career Development) and Education Component$83,600
U54 · FY2015 · NS · contact PI
Natural History of Hexosaminidase Deficiency and Other Gangliosidoses and Synger-G$54,117
U54 · FY2015 · NS · contact PI
MR Spectroscopy to Determine Neuroinflammation and Oxidative Stress in MPS I (NESTRASIL)$45,600
U54 · FY2015 · NS · contact PI
Lysosomal Disease Network$1,249,987
U54 · FY2014 · NS · contact PI
Gene Therapy for Metabolic Disorders$1,198,865
P01 · FY2014 · HD · contact PI
RDCRC Administrative Unit$314,158
U54 · FY2014 · NS · contact PI
AAV Mediated Gene Therapy to the CNS for MPS I$278,876
P01 · FY2014 · HD · contact PI
SB Transposons for Gene Therapy$268,882
P01 · FY2014 · HD · contact PI
In Vivo Lentiviral Gene Therapy for Hurler Syndrome$226,946
P01 · FY2014 · HD · contact PI
Neuro-Histology & Behavior$175,732
P01 · FY2014 · HD · contact PI
Longitudinal Studies of Brain Structure and Function in MPS Disorders$154,280
U54 · FY2014 · NS · contact PI
Research Animal Care and Medicine$141,487
P01 · FY2014 · HD · contact PI
Administration$106,942
P01 · FY2014 · HD · contact PI
Training (Career Development) and Education Component$83,600
U54 · FY2014 · NS · contact PI
Natural History of Hexosaminidase Deficiency and Other Gangliosidoses and Synger-G$63,717
U54 · FY2014 · NS · contact PI
MR Spectroscopy to Determine Neuroinflammation and Oxidative Stress in MPS I (NESTRASIL)$45,600
U54 · FY2014 · NS · contact PI
The Lysosomal Disease Network's 10th Annual WORLD Symposium$20,000
R13 · FY2014 · NS · contact PI
Lysosomal Disease Network$1,248,724
U54 · FY2013 · NS · contact PI
Gene Therapy for Metabolic Disorders$1,143,424
P01 · FY2013 · HD · contact PI
SB Transposons for Gene Therapy$245,721
P01 · FY2013 · HD · contact PI
In Vivo Lentiviral Gene Therapy for Hurler Syndrome$217,347
P01 · FY2013 · HD · contact PI
AAV Mediated Gene Therapy to the CNS for MPS I$215,296
P01 · FY2013 · HD · contact PI
Research Animal Care and Medicine$197,544
P01 · FY2013 · HD · contact PI
Neuro-Histology & Behavior$167,396
P01 · FY2013 · HD · contact PI
Administration$100,120
P01 · FY2013 · HD · contact PI
RDCRC Administrative Unit$96,337
U54 · FY2013 · NS · contact PI
The Lysosomal Disease Network's 10th Annual WORLD Symposium$15,000
R13 · FY2013 · NS · contact PI
Lysosomal Disease Network$1,246,964
U54 · FY2012 · NS · contact PI
Gene Therapy for Metabolic Disorders$1,173,691
P01 · FY2012 · HD · contact PI
SB Transposons for Gene Therapy$250,274
P01 · FY2012 · HD · contact PI
AAV Mediated Gene Therapy to the CNS for MPS I$226,469
P01 · FY2012 · HD · contact PI
In Vivo Lentiviral Gene Therapy for Hurler Syndrome$224,073
P01 · FY2012 · HD · contact PI
Research Animal Care and Medicine$190,914
P01 · FY2012 · HD · contact PI
Neuro-Histology & Behavior$173,877
P01 · FY2012 · HD · contact PI
Administration$108,084
P01 · FY2012 · HD · contact PI
RDCRC Administrative Unit$96,377
U54 · FY2012 · NS · contact PI
Lysosomal Disease Network-9th Annual WORLD Symposium$28,301
R13 · FY2012 · NS · contact PI
Lysosomal Disease Network-8th Annual WORLD Symposium$16,000
R13 · FY2012 · HD · contact PI
Lysosomal Disease Network$1,244,214
U54 · FY2011 · NS · contact PI
Gene Therapy for Metabolic Disorders$1,149,228
P01 · FY2011 · HD · contact PI
SB Transposons for Gene Therapy$235,522
P01 · FY2011 · HD · contact PI
AAV Mediated Gene Therapy to the CNS for MPS I$228,118
P01 · FY2011 · HD · contact PI
In Vivo Lentiviral Gene Therapy for Hurler Syndrome$222,057
P01 · FY2011 · HD · contact PI
Research Animal Care and Medicine$181,673
P01 · FY2011 · HD · contact PI
Neuro-Histology & Behavior$173,100
P01 · FY2011 · HD · contact PI
Administration$108,758
P01 · FY2011 · HD · contact PI
RDCRC Administrative Unit$96,779
U54 · FY2011 · NS · contact PI
Lysosomal Disease Network$1,392,315
U54 · FY2010 · NS · contact PI
RDCRC Administrative Unit$116,877
U54 · FY2010 · NS · contact PI
Lysosomal Disease Network$107,310
U54 · FY2010 · NS · contact PI
WORLD Symposium 2010 (Lysosomal Disease Network's 6th Annual Research Meeting)$35,000
R13 · FY2010 · NS · contact PI
Lysosomal Disease Network$1,355,165
U54 · FY2009 · NS · contact PI
RDCRC Administrative Unit$112,108
U54 · FY2009 · NS · contact PI
WORLD Symposium 2009 (Lysosomal Disease Network's 5th Annual Research Meeting)$20,000
U13 · FY2009 · NS · contact PI
PKU-007: A PHASE 2, MULTICENTER, OPEN-LABEL STUDY TO EVALUATE THE SAFETY AND EFF$1,830
M01 · FY2009 · RR · contact PI
PKU-008: PHENOPTIN IN PHENYLKETONURIA$1,463
M01 · FY2009 · RR · contact PI
Gene Therapy for Metabolic Disorders$1,086,784
P01 · FY2008 · HD · contact PI
Lentiviral gene therapy for MPS type I$205,926
P01 · FY2008 · HD · contact PI
Lysosomal Disease Network-4th Annual WORLD Symposium$30,000
R13 · FY2008 · NS · contact PI
PKU-008: PHENOPTIN IN PHENYLKETONURIA$3,092
M01 · FY2008 · RR · contact PI
PKU-007: A PHASE 2, MULTICENTER, OPEN-LABEL STUDY TO EVALUATE THE SAFETY AND EFF$1,766
M01 · FY2008 · RR · contact PI
Gene Therapy for Metabolic Disorders$1,076,684
P01 · FY2007 · HD · contact PI
Lentiviral gene therapy for MPS type I$204,020
P01 · FY2007 · HD · contact PI
Lysosomal Disease Network-3rd Annual WORLD Symposium$20,000
R13 · FY2007 · NS · contact PI
A PHASE 3, MULTICENTER, OPEN-LABEL EXTENSION STUDY OF PHENOPTIN IN SUBJECTS WITH$8,604
M01 · FY2007 · RR · contact PI
PKU-007: A PHASE 2, MULTICENTER, OPEN-LABEL STUDY TO EVALUATE THE SAFETY AND EFF$2,244
M01 · FY2007 · RR · contact PI
PKU-008: PHENOPTIN IN PHENYLKETONURIA$1,122
M01 · FY2007 · RR · contact PI
Gene Therapy for Metabolic Disorders$1,076,565
P01 · FY2006 · HD · contact PI
Lentiviral gene therapy for MPS type I$193,288
P01 · FY2006 · HD · contact PI
AGAL-02503: MULTI-CENTER, OPEN-LABEL STUDY OF THE SAFETY AND EFFICACY OF FABRAZY$26,542
M01 · FY2006 · RR · contact PI
A PHASE 2, MULTICENTER, OPEN-LABEL STUDY TO EVALUATE THE RESPONSE TO AND SAFETY$19,010
M01 · FY2006 · RR · contact PI
PKU-003 PHASE 3 PHENOPTIN IN PKU$8,967
M01 · FY2006 · RR · contact PI
A PHASE 3, MULTICENTER, OPEN-LABEL EXTENSION STUDY OF PHENOPTIN IN SUBJECTS WITH$2,152
M01 · FY2006 · RR · contact PI
Gene Therapy for Metabolic Disorders$1,070,384
P01 · FY2005 · HD
Lentiviral gene therapy for MPS type I$187,655
P01 · FY2005 · HD
AGAL-02503: MULTI-CENTER, OPEN-LABEL STUDY OF THE SAFETY AND EFFICACY OF FABRAZY$48,090
M01 · FY2005 · RR
Lysosomal Disease Network-2nd Annual WORLD Symposium$20,000
R13 · FY2005 · NS
Gene Therapy for Metabolic Disorders$1,053,877
P01 · FY2004 · HD
Lentiviral gene therapy for MPS type I$182,189
P01 · FY2004 · HD
WORLD Lysosomal Research Network Annual Symposium$25,000
R13 · FY2004 · NS
WORLD Lysosomal Research Network Annual Symposium$24,600
R13 · FY2004 · NS
GENE THERAPY FOR METABOLIC DISORDERS$1,097,499
P01 · FY2002 · HD
GENE THERAPY FOR METABOLIC DISORDERS$6,727
P01 · FY2002 · HD
GENE THERAPY FOR METABOLIC DISORDERS$1,061,927
P01 · FY2001 · HD
LENTIVIRAL EX VIVO HEMATOPOIETIC STEM CELL GENE THERAPY FOR MPS I$106,204
P01 · FY2001 · HD
GENE THERAPY FOR METABOLIC DISORDERS$35,472
P01 · FY2001 · HD
LENTIVIRAL EX VIVO HEMATOPOIETIC STEM CELL GENE THERAPY FOR MPS I$0
P01 · FY2001 · HD
GENE THERAPY FOR METABOLIC DISORDERS$1,061,040
P01 · FY2000 · HD
LENTIVIRAL EX VIVO HEMATOPOIETIC STEM CELL GENE THERAPY FOR MPS I$106,204
P01 · FY2000 · HD